APIXABAN
apixaban 2.5 mg tablet, 60
APIXABAN (13464P)
13464P
Body System:
Manner of administration:Oral
Restriction 14301
Indication: Prevention of stroke or systemic embolism
Restriction 14300
Indication: Prevention of recurrent venous thromboembolism
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 120 | # of repeats: 5 | DPMQ: $125.70 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Eliquis | |||||